Choksi Laboratories Ltd vs Dr Lalchandani Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 30, 2026

Key Highlights

The Latest Trading Price of Choksi Laboratories Ltd is ₹ 204.8 as of 29 Oct 15:30 . The P/E Ratio of Choksi Laboratories Ltd changed from 84.7 on March 2022 to 36.7 on March 2026 . This represents a CAGR of -15.40% over 5 yearsThe P/E Ratio of Dr Lalchandani Labs Ltd changed from 6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Choksi Laboratories Ltd changed from ₹ 5.5 crore on March 2021 to ₹ 72.16 crore on March 2026 . This represents a CAGR of 53.58% over 6 yearsThe Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 6.02 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Choksi Laboratories Ltd for the Jun '26 is ₹ 12.08 crore as compare to the Mar '26 revenue of ₹ 12.88 crore. This represent the decline of -6.21% The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Choksi Laboratories Ltd for the Jun '26 is ₹ 3.3 crore as compare to the Mar '26 ebitda of ₹ 3.71 crore. This represent the decline of -11.05% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Choksi Laboratories Ltd changed from ₹ 0.42 crore to ₹ 0.58 crore over 9 quarters. This represents a CAGR of 15.43% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Choksi Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Choksi Laboratories Ltd

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services.
CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries.
The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services. The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day.
It provides calibration of production & quality control equipment with traceability to national / international standards.
This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects.

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

FAQs for the comparison of Choksi Laboratories Ltd and Dr Lalchandani Labs Ltd

Which company has a larger market capitalization, Choksi Laboratories Ltd or Dr Lalchandani Labs Ltd?

Market cap of Choksi Laboratories Ltd is 142 Cr while Market cap of Dr Lalchandani Labs Ltd is 6 Cr

What are the key factors driving the stock performance of Choksi Laboratories Ltd and Dr Lalchandani Labs Ltd?

The stock performance of Choksi Laboratories Ltd and Dr Lalchandani Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Choksi Laboratories Ltd and Dr Lalchandani Labs Ltd?

As of October 30, 2026, the Choksi Laboratories Ltd stock price is INR ₹204.8. On the other hand, Dr Lalchandani Labs Ltd stock price is INR ₹6.95.

How do dividend payouts of Choksi Laboratories Ltd and Dr Lalchandani Labs Ltd compare?

To compare the dividend payouts of Choksi Laboratories Ltd and Dr Lalchandani Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.